39783 |
Oncology |
Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Rela... |
CANCER MANAG RES 2021 10.2147/CMAR.S309092 |
김석진 |
2021 |
39782 |
Medicine, General & Internal |
Real-world data on the survival outcome of patients with newly diagnos... |
KOREAN J INTERN MED 2021 10.3904/kjim.2019.367 |
김석진 |
2021 |
39781 |
Oncology |
Impact of transformation on the survival of patients diagnosed with fo... |
J CANCER 2021 10.7150/jca.54434 |
김석진 |
2021 |
39780 |
Oncology |
Exosomal miR-1305 in the oncogenic activity of hypoxic multiple myelom... |
J CANCER 2021 10.7150/jca.55553 |
김석진 |
2021 |
39779 |
Oncology; Health Care Sciences & Services; Rehabilitation |
Impact of depression on adherence to lenalidomide plus low-dose dexame... |
SUPPORT CARE CANCER 2021 10.1007/s00520-021-06017-y |
김석진 |
2021 |
39778 |
Oncology |
The mutation of BCOR is highly recurrent and oncogenic in mature T-cel... |
BMC CANCER 2021 10.1186/s12885-021-07806-8 |
김석진 |
2021 |
39777 |
Multidisciplinary Sciences |
Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT... |
SCI REP-UK 2021 10.1038/s41598-021-88815-2 |
김석진 |
2021 |
39776 |
Oncology |
Real-world outcomes of ibrutinib therapy in Korean patients with relap... |
CANCER COMMUN 2021 10.1002/cac2.12150 |
김석진 |
2021 |
39775 |
Oncology |
Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in... |
FRONT ONCOL 2021 10.3389/fonc.2021.669817 |
김석진 |
2021 |
39774 |
Oncology |
Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse... |
FRONT ONCOL 2021 10.3389/fonc.2021.628807 |
김석진 |
2021 |